Lava Therapeutics Nv Reports Results For The Quarter Ended In June: Earnings Summary

LAVA Therapeutics NV

20/08/2024 14:51

* LAVA Therapeutics NV  LVTX.OQ  reported a quarterly
adjusted
loss of 31 cents​​ per share for the quarter ended in June,
higher than the same quarter last year, when the company
reported EPS of -48 cents.  The mean expectation of two analysts
for the quarter was for a loss of 36 cents per share. Wall
Street expected results to range from -38 cents to -34 cents per
share.
    * Reported revenue was zero​; analysts expected zero. 
    * LAVA Therapeutics NV's reported EPS for the quarter was a
loss
of 31 cents​.
    * The company reported a quarterly loss of $8.3 million.
    * LAVA Therapeutics NV shares had risen by 1.1% this
quarter and
gained 15.2% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 17.2%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 5 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "strong buy"

Wall Street's median 12-month price target for LAVA Therapeutics
NV is $6.00 
This summary was machine generated from LSEG data August 20 at
01:51 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -0.36          -0.31          Beat
 Mar. 31 2024      -0.12          -0.02          Beat
 Dec. 31 2023      -0.12          -0.24          Missed
 Sep. 30 2023      -0.49          -0.34          Beat